New COVID-19 vaccine a good value for US, University of Michigan team finds
Economic model created for CDC shows that in older adults promoting updated vaccination will save the US money, while in other adults it should be reasonably cost effective.
We're still accepting applications for Fall 2026!
Apply Today
Economic model created for CDC shows that in older adults promoting updated vaccination will save the US money, while in other adults it should be reasonably cost effective.
Earlier this year, Serbian professor and public health researcher Bosiljka Djikanovic visited the University of Michigan School of Public Health as part of a faculty development program hosted by the Weiser Center for Europe and Eurasia.
The Food and Drug Administration’s expert vaccine advisory panel on Thursday unanimously endorsed the idea of taking a strain of influenza viruses that no longer appears to circulate out of flu shots as quickly as possible, pressing the FDA and manufacturers to try to get the work done on an expedited timeline.
David Hutton, a professor of Health Management and Policy and Global Public Health, discusses the cost-effectiveness of RSV vaccination in older adults. Hutton and a group of University of Michigan researchers recently presented research on the topic during a meeting for the CDC's Advisory Committee on Immunization Practices (ACIP).
Matthew Boulton, Senior Associate Dean for Global Public Health, was quoted in Detroit Free Press. He stated it is important for the public to be updated with their polio vaccines.
Identifying adults who are ambivalent about vaccines early in a pandemic and finding community leaders who can help spread reliable information within their communities could help reduce vaccine hesitancy, according to a new University of Michigan study.